Recent Quotes
My Watchlist
Indicators
Local Stocks
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Longboard Pharmaceuticals Inc (NQ: LBPH )

59.75 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Longboard Pharmaceuticals Inc

< Previous 1 2 3 4 5 Next >
Longboard Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference
From Longboard Pharmaceuticals, Inc.
Via Business Wire
Citigroup Maintains Buy Rating for Longboard Pharmaceuticals: Here's What You Need To Know
Via Benzinga
Longboard Pharmaceuticals Reports Full Year 2022 Financial Results and Key Corporate Initiatives
From Longboard Pharmaceuticals, Inc.
Via Business Wire
Earnings Preview: Longboard Pharmaceuticals
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap... 
Via Benzinga
Longboard Pharmaceuticals to Report Full Year 2022 Financial Results and Key Corporate Initiatives on March 2, 2023
From Longboard Pharmaceuticals, Inc.
Via Business Wire
Longboard Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Common Stock
From Longboard Pharmaceuticals
Via Business Wire
Longboard Pharmaceuticals Announces Pricing of Public Offering of Common Stock
From Longboard Pharmaceuticals, Inc.
Via Business Wire
Longboard Pharmaceuticals Announces Commencement of Public Offering of Common Stock
From Longboard Pharmaceuticals, Inc.
Via Business Wire
Longboard Pharmaceuticals Announces Positive Topline Data from a Phase 1 Clinical Study Evaluating Central Nervous System Pharmacokinetics and Pharmacodynamics of LP352 in Healthy Volunteers
From Longboard Pharmaceuticals, Inc.
Via Business Wire
Longboard Pharmaceuticals’ Presence at American Epilepsy Society (AES) Annual Meeting Reinforces Ongoing Commitment to the Rare Epilepsy Community
From Longboard Pharmaceuticals, Inc.
Via Business Wire
Longboard Pharmaceuticals to Present at Guggenheim’s Healthcare Talks 4th Annual Immunology and Neurology Day
From Longboard Pharmaceuticals, Inc.
Via Business Wire
Longboard Pharmaceuticals: Q3 Earnings Insights
Longboard Pharmaceuticals (NASDAQ:LBPH) reported its Q3 earnings results on Thursday, November 3, 2022 at 08:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2022 Financial Results
From Longboard Pharmaceuticals, Inc.
Via Business Wire
Longboard Pharmaceuticals to Participate in the Cantor Neurology & Psychiatry Conference
From Longboard Pharmaceuticals, Inc.
Via GlobeNewswire
This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the potential development of a novel monkeypox vaccine using its norovirus... 
Via Benzinga
The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday
Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Schenker and USA Truck announced plans to combine and create premier North American transportation... 
Via Benzinga
The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight
Biopharma stocks outperformed the broader market in the week ending April 2, thereby recouping the losses from the previous week. Clinical readouts and FDA decisions were among the chief catalysts that... 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 216 stocks hit new 52-week lows. 
Via Benzinga
Longboard Pharmaceuticals: Q1 Earnings Insights
Longboard Pharmaceuticals (NASDAQ:LBPH) reported its Q1 earnings results on Thursday, March 3, 2022 at 04:05 PM. Here's what investors need to know about the... 
Via Benzinga
40 Stocks Moving In Tuesday's Mid-Day Session
Gainers Orbsat Corp. (NASDAQ: OSAT) shares jumped 81.7% to $12.12 after the company announced its Global Telesat Communications unit has entered into an agreement with Alibaba.... 
Via Benzinga
Mid-Morning Market Update: Markets Mixed; JPMorgan Beats Q2 Views
Following the market opening Tuesday, the Dow traded down 0.25% to 34,908.83 while the NASDAQ rose 0.15% to 14,754.89. The S&P also fell, dropping 0.07% to 4,381.77. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
60 Biggest Movers From Yesterday
Gainers RAPT Therapeutics, Inc. (NASDAQ: RAPT) shares jumped 115.5% to settle at $40.02 on Monday as the company announced topline results from its Phase 1b trial of RPT193 as... 
Via Benzinga
The Daily Biotech Pulse: Hookipa, PDS Biotech Report Positive Data, Ironwood CFO To Depart, Decision Day For Vertex
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 7) Agios Pharmaceuticals, Inc... 
Via Benzinga
64 Biggest Movers From Friday
Gainers Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares gained... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.